Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Key points EUS-guided pancreatic chemoablation has emerged as an innovative, promising, and minimally invasive approach for the treatment of appropriately selected neoplastic type pancreatic cysts. When performed at expert centers, the treatment response appears durable in majority of patients at long-term follow-up. EUS-RFA is an innovative minimally invasive treatment option for appropriately selected solid pancreatic mass lesions. The procedure is associated with a 10% to 15%…
Key points An anastomosis can be established between the stomach and the jejunum under endoscopic ultrasound (EUS)-guidance in patients with gastric outlet obstruction. A lumen-apposing metal stent (LAMS) can be deployed either directly or via assisted-techniques using fluoroscopic and sonographic guidance. EUS-gastroenterostomy carries a higher technical and clinical success without serious adverse event. While experience is limited, the preliminary data appear promising. Transgastric endoscopic retrograde cholangiopanceratography…
Key points Endoscopic ultrasonography (EUS)-guided celiac plexus interventions consist of the injection of neurolytic agents or steroids into ganglia to produce neurolysis or temporary block. Celiac plexus block or neurolysis is the most common EUS-guided intervention in current practice. Significant pain control is achieved with the injection of ethanol in the setting of pancreatic cancer. More modest results are seen in patients with abdominal pain arising…
Key points In patients who are unfit for surgery, percutaneous drainage, endoscopic transpapillary drainage and EUS-guided drainage are all effective and safe alternative procedures to cholecystectomy EUS-guided drainage is preferred over percutaneous technique due to similar rates of technical success and reduced rates of reintervention and unplanned readmission EUS-guided drainage is associated with a steeper learning curve and should be performed only in high-volume endoscopy centers…
Key points Endoscopic ultrasonography-guided biliary drainage (EUS-BD) is now generally preferred over percutaneous methods in patients with biliary obstruction and failed biliary cannulation during endoscopic retrograde cholangiopancreatography (ERCP), and should be considered in those with an inaccessible papilla. EUS-BD is gaining popularity as an alternative for patients with nonresectable malignant hilar strictures and inadequate drainage of the left liver lobe by ERCP. EUS-guided pancreatic duct drainage…
Key points Recognition of different types of pancreatic fluid collections is crucial for appropriate management. EUS-guided drainage is the treatment of choice in the management of pancreatic pseudocysts, with clinical outcomes comparable to surgical cystogastrostomy. The management of walled-off necrosis (WON) is more complex. If the percutaneous/surgical and the endoscopic approach are both feasible and available, the endoscopic approach is preferred. Management is multidisciplinary and is…
Key points Communication between the endosonographer and the cytopathologist is the key to a successful EUS FNA service. A cytopathology service should be involved early in the planning process for establishing an EUS-guided tissue acquisition service. Using an algorithmic approach to diagnosing a patient will facilitate a correct diagnosis. Conceptual breakthroughs, based on developed theories, and discoveries in science bring accolades. Advances in the biotechnology field…
Key points Endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) with cutting-type needles has replaced EUS-fine-needle aspiration (FNA) as the current gold standard for optimal tissue acquisition. EUS-FNA with or without cell block remains an excellent alternative when access to FNB is limited or deemed unnecessary. 22-g needles provide better histological yield when performing FNB on solid masses, but 25-g needles should be used for FNA. 19-g FNA…
Key points Anal endosonography (AES) is simple to perform and visualizes the anal sphincter complex, notably the external and internal anal sphincters. AES is able to image sphincter tears and defects. AES can also characterize sphincter morphology and determine muscular quality. AES is the single most important investigation for patients with anal incontinence. Introduction First described in 1989, anal endosonography (AES) was the first technique to…
Key points The importance of nodal status guiding therapeutic decision making is increasingly recognized for rectal cancer. Endoscopic ultrasonography (EUS) fine-needle aspiration or biopsy (FNA or FNB, respectively) is recognized as being an essential component of locoregional clinical staging. Although EUS still has insufficient accuracy for T-staging, EUS FNA can accurately predict patients who have evidence of iliac vessel node disease by upstaging 7% of patients…
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
Key points In patients with low-to-moderate clinical probability of common bile duct (CBD) stones, EUS or MRCP is recommended before endoscopic retrograde cholangiopancreatography (ERCP) is performed. In patients with acute pancreatitis of unknown origin or right upper quadrant pain with normal transabdominal ultrasound, EUS should be considered. In patients with a CBD stricture of unknown origin, EUS should be performed and, if inconclusive, ERCP should follow…
Key points The differential diagnosis of pancreatic cystic lesions is wide: the majority of these lesions are benign, but detection of mucin-producing pancreatic cysts (IPMNs and MCNs) is important because these cysts have malignant potential and may harbor pancreatic adenocarcinoma. The diagnostic accuracy of EUS based on morphology alone is limited. A combination of EUS features, fluid cytology, CEA, and molecular markers is used to differentiate…
Key points Endoscopic ultrasound (EUS) is the most sensitive imaging modality for the diagnosis of pancreatic ductal adenocarcinoma, especially lesions less than 2 cm in size. EUS is also the most sensitive imaging modality for the detection of small pancreatic neuroendocrine tumors (PNETs) and is superior to both computed tomography (CT) and magnetic resonance imaging (MRI). CT is the most accurate modality for the determination of…
Key points EUS imaging is subjective and often nonspecific in inflammatory diseases of the pancreas; therefore, the clinical history and presentation are important when making a final diagnosis. EUS fine-needle aspiration (FNA) in inflammatory diseases of the pancreas is predominately used to exclude/diagnose superimposed malignant processes; the role of fine-needle biopsy (FNB) remains to be defined. Complementary imaging modalities such as elastography and contrast-enhanced imaging are…
Pancreas Successful pancreatic imaging requires the ability to image the entire gland. In general, the body and tail of the pancreas are imaged through the posterior wall of the stomach, and, in most cases, the transgastric approach provides images of the genu (neck) of the pancreas as well. Complete imaging of the pancreatic head, however, requires placement of the transducer in three different positions within the…
Key points EUS can accurately differentiate a mural lesion from extrinsic compression against the gut wall. Imaging diagnosis of subepithelial lesions with EUS is based on its layer of origin and internal echo characteristics. Contrast-enhanced harmonic EUS and EUS elastography can help to differentiate and predict malignancy potential of subepithelial lesions. EUS-guided tissue acquisition is useful for pathologic diagnosis of subepithelial lesions. Endoscopic therapeutic methods for…
You’re Reading a Preview Become a Clinical Tree membership for Full access and enjoy Unlimited articles Become membership If you are a member. Log in here
Key points Criteria exist to differentiate benign from malignant mediastinal lymph nodes, but used alone, these criteria are not sufficiently accurate. Endoscopic ultrasonography-guided fine-needle aspiration (EUS FNA) for cytopathologic evaluation is required to make sound clinical decisions. The overall accuracy for the diagnosis of posterior mediastinal malignancies with transesophageal EUS FNA is greater than 90%. EUS FNA and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) are the…
KEY POINTS EUS is useful to stage newly diagnosed esophageal and gastric cancer with no metastatic disease on CT +/- PET – EUS is most accurate in distinguishing between T1-2 versus T3-4 disease, and in the staging of more advanced disease. EUS has a limited role in staging superficial esophageal and gastric cancer EUS-guided fine needle aspiration or biopsy of suspicious lymph nodes or metastatic disease…